About Rebus Biosystems
Rebus Biosystems is a company based in Santa Clara (United States) founded in 2006 by Ron Cook and Josh Ryu.. Rebus Biosystems has raised $20 million across 2 funding rounds from investors including HHS, Seegene Technologies and Lifecore. Rebus Biosystems operates in a competitive market with competitors including 10X Genomics, Mission Bio, Singleron, Cellares and LUMICKS, among others.
- Headquarter Santa Clara, United States
- Founders Ron Cook, Josh Ryu
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20 M (USD)
in 2 rounds
-
Latest Funding Round
$20 M (USD), Series B
Nov 19, 2020
-
Investors
HHS
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Rebus Biosystems
Rebus Biosystems has successfully raised a total of $20M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $20.0M
-
First Round
First Round
(23 Sep 2009)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Series B - Rebus Biosystems | Valuation | Illumina Ventures | |
| Sep, 2009 | Amount | Grant - Rebus Biosystems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rebus Biosystems
Rebus Biosystems has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Seegene Technologies and Lifecore. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by Seoul-based Ncore Ventures.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rebus Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rebus Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rebus Biosystems Comparisons
Competitors of Rebus Biosystems
Rebus Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Singleron, Cellares and LUMICKS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| domain | founded_year | HQ Location |
Single-cell imaging platform developed via magnetic levitation technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rebus Biosystems
Frequently Asked Questions about Rebus Biosystems
When was Rebus Biosystems founded?
Rebus Biosystems was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Where is Rebus Biosystems located?
Rebus Biosystems is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Who is the current CEO of Rebus Biosystems?
Paul Sargeant is the current CEO of Rebus Biosystems.
Is Rebus Biosystems a funded company?
Rebus Biosystems is a funded company, having raised a total of $20M across 2 funding rounds to date. The company's 1st funding round was a Grant of $2.24M, raised on Sep 23, 2009.
What does Rebus Biosystems do?
Founded in 2006 and based in Santa Clara, United States, operations focus on biotechnology and spatial omics. Patented Synthetic Aperture Optics technology is utilized for analyzing multiple gene expressions in single cells, enabling subcellular resolution imaging of full tissue sections via laser beams. The Rebus Esper platform is integrated with advancements in imaging, fluidics, chemistry, and bioinformatics to provide spatial omics data.
Who are the top competitors of Rebus Biosystems?
Rebus Biosystems's top competitors include 10X Genomics, Mission Bio and Cellares.
Who are Rebus Biosystems's investors?
Rebus Biosystems has 9 investors. Key investors include HHS, Seegene Technologies, Lifecore, Illumina Ventures, and Ncore Ventures.